Chevy Chase Clinical Research
Working together to bring the most promising treatments to you
At Chevy Chase Clinical Research, our dedicated team of GI experts, researchers, and physicians works together to bring the most promising new treatments to patients across the Washington, DC area – before they’re available anywhere else. Our experience is unmatched in the area: We have been providing GI-specific clinical trials to our patients for more than 30 years.
If the standard medications are not working for your specific GI condition, our multidisciplinary team may be able to help. We offer participants access to leading-edge therapies only available through clinical trials.
What is a clinical trial?
A clinical trial is a study of a new medical or surgical technology, medicine, device, or technique. In phases I and II of a clinical trial, researchers determine if a new medication (for example) is safe and effective. In a phase III clinical trial, like those we offer at Chevy Chase Clinical Research, we’re helping to find out how well a medication performs over time. Phase III trials test therapies that researchers already know are safe and effective from trials in the earlier phases.
Clinical trials are a key part of how we move the field of medicine forward. Today’s medical breakthroughs are the result of clinical trials conducted in the past.
What does this mean for you? Participating in a clinical trial means that you can get access to the latest medications for some of the most common GI conditions – before they become available to everyone else.
What are the benefits of participating in a clinical trial?
- You get access to medicines that are not yet available, which in some cases opens up a whole new category of safe and effective treatments for your GI condition.
- You’ll be followed closely by our expert team of GI physicians, which means you’ll get top-notch, personalized care using a concierge medicine approach
- All of your study-related expenses are covered, and you’ll often receive care at no additional cost to you.
What clinical trials does Chevy Chase Clinical Research offer?
At any given time, Chevy Chase Clinical Research has 12 to 15 active phase III clinical trials. They cover a range of diseases, including:
- Gastroparesis
- Ulcerative colitis
- Crohn’s disease
- Celiac disease
- Nonalcoholic fatty liver disease
- Recurrent C. difficile
- Eosinophilic esophagitis
- Gastroesophageal reflux disease
- Colorectal cancer
- Metabolic dysfunction-associated steatohepatitis
- Weight loss
- Celiac disease
- Primary sclerosing cholangitis
Why choose Chevy Chase Clinical Research to participate in a GI clinical trial?
We’re highly experienced
Chevy Chase Clinical Research is the longest operating GI clinical trials site in the Washington, DC area, with 30+ years of clinical trials experience. Two of our physician scientists were lead researchers in GI-related studies that were recently featured in the New England Journal of Medicine.
You get the best medicines
Through our clinical trials, we’re able to provide you breakthrough medications, offering the most promising new treatments for GI diseases. And in most cases, you can stay on the medicines if they’re working for you – even after the trial ends.
You get 360-degree concierge care
We have a dedicated team including research coordinators who are experts in GI diseases and physicians who oversee and are involved in the care of our research patients. That means we provide excellent, holistic care to make sure all of your needs are met while you’re in the clinical trial.
Reduced cost of care
Your medications and all study-related costs are often covered by the trial.
We have a strong tradition of excellence
For example, all of the new biological medicines for inflammatory bowel disease are available today due in large part to clinical trials our patients participated in.
We choose the most promising trials
We’re selective about the studies we choose, and we focus on addressing diseases where there aren’t already great treatment options.
We bridge clinical research and clinical care
We’re selective about the studies we choose, and we focus on addressing diseases where there aren’t already great treatment options.
